News
HOLX
78.63
+0.96%
0.75
Hologic Inc <HOLX.OQ> expected to post earnings of $1.02 a share - Earnings Preview
Hologic Inc. Expected to post earnings of $1.02 a share. The company is expected to report a 1.6% increase in quarterly revenue to $1 billion from $984.4 million a year ago. Hologic will report results on July 29 for the period ending June 30 2024.
Reuters · 5h ago
Hologic (HOLX) Buys Endomag to Boost Breast Cancer Solutions
NASDAQ · 9h ago
$1000 Invested In Hologic 10 Years Ago Would Be Worth This Much Today
Hologic has outperformed the market over the past 10 years by 1.0% on an annualized basis. The company has an average annual return of 11.71%. Hologic has a market capitalization of $17.55 billion. If an investor bought $1000 of HOLX stock 10 years ago, it would be worth $3,078.
Benzinga · 1d ago
Alphatec's (ATEC) New EOS Insight System to Boost Spine Care
NASDAQ · 1d ago
*Hologic Completes Acquisition Of Endomagnetics Ltd >HOLX
Dow Jones · 1d ago
Reasons to Add The Cooper Companies (COO) to Your Portfolio Now
NASDAQ · 2d ago
Here's Why You Should Retain QuidelOrtho (QDEL) Stock for Now
NASDAQ · 3d ago
U.S. RESEARCH ROUNDUP-Colgate-Palmolive, McKesson, Microsoft
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Colgate-Palmolive, McKesson, Microsoft and Air Products & Chemicals among those. AIG, AIG and others have seen their target prices cut by some analysts.
Reuters · 3d ago
HOLOGIC INC <HOLX.O>: STEPHENS RAISES TARGET PRICE TO $92 FROM $87
Reuters · 3d ago
Boston Scientific (BSX) Banks on Global Expansion, Innovation
NASDAQ · 4d ago
Glaukos (GKOS) Gains 51.9% YTD: What's Driving the Stock?
NASDAQ · 4d ago
Weekly Report: what happened at HOLX last week (0715-0719)?
Weekly Report · 4d ago
Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?
Hologic, Inc. (NASDAQ:HOLX) is trading around its fair value. The company's share price has risen to US$78.11 in recent months. Hologic is expected to double in the next few years. However, the company is still 16% below its intrinsic value. Is Hologic currently undervalued? We look at the company's outlook and growth potential.
Simply Wall St · 5d ago
GE HealthCare (GEHC) New Deal to Aid Its Ultrasound Portfolio
NASDAQ · 07/19 15:58
Intuitive Surgical (ISRG) Q2 Earnings Beat, Procedures Robust
NASDAQ · 07/19 14:02
Hologic's (HOLX) Surgical Business Set to Propel Q3 Earnings
NASDAQ · 07/19 12:55
Hyperfine's (HYPR) Swoop System Gets New FDA-Cleared Software
NASDAQ · 07/18 16:30
Smith & Nephew's (SNN) CATALYSTEM System Gets FDA Clearance
NASDAQ · 07/17 16:27
Hologic's Q3 2024 Earnings: What to Expect
Hologic, Inc. Is expected to unveil its fiscal Q3 earnings results after the market closes on Monday, Jul. 29. The company specializes in developing and supplying diagnostics, medical imaging systems, and surgical products focused on women's health. Shares of HOLX have risen 11.2% over the past year.
Barchart · 07/17 13:43
Pre Q3 Earnings: Is Hologic (HOLX) Stock a Portfolio Must-Have?
NASDAQ · 07/17 13:10
More
Webull provides a variety of real-time HOLX stock news. You can receive the latest news about Hologic Inc through multiple platforms. This information may help you make smarter investment decisions.
About HOLX
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. It operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. The Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.